Neuphoria Therapeutics Inc.

NEUP · Nasdaq · SIC 2834: Pharmaceutical Preparations
87
SEC Filings

Business Summary

. Overview We are a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. Neuphoria is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the 7 nicotinic acetylcholine ("ACh") receptor ("a7 receptor") for the acute, as needed treatment of social anxiety disorder (SAD) and for chronic treatment of post-traumatic stress disorder (PTSD). The...

Next Earnings

Q2 FY2026 — expected 2026-09-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNEUPdiscussed_in_filing Cybersecurity
topic_mentionNEUPdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-09-292025-06-300001193125-25-223338EDGAR103K words
2024-09-302024-06-300001213900-24-082909EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001193125-26-054509EDGAR25K words
2025-11-142025-09-300001193125-25-281579EDGAR—
2025-05-202025-03-310000950170-25-075175EDGAR—
2025-02-142024-12-310000950170-25-020473EDGAR—
2024-11-142024-09-300000950170-24-127032EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-01-080001213900-26-002245EDGAR7K words
2025-12-180001213900-25-123289EDGAR—
2025-12-170001213900-25-122777EDGAR—
2025-10-270001213900-25-102607EDGAR—
2025-10-200001213900-25-100371EDGAR—
2025-09-160001213900-25-087950EDGAR—
2025-07-180001213900-25-065723EDGAR—
2025-05-200001213900-25-045970EDGAR—
2025-01-140001213900-25-003492EDGAR—
2024-12-230001213900-24-112016EDGAR—

87 total filings indexed. 70 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001191070
TickerNEUP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedC3

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: cceedb62f5f5cb5e821549e59a6ef109251c46a1b0dd11ae5dbd1ebec30c0c74
parent: 3abcde7ded987c8d9c2c468a87a069449de56c91748383c82c499f090835e836
content hash: 953316213fe63434947b94546a4772bf3ba89c9b60ae69ce438e94449ed7629c
signed: 2026-04-13T04:46:28.823Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf